ConductScience.org, home

Paper36917125

The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again?

Chakraborty C and 5 others. Int J Surg, 2023. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again? Papers, record 36917125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36917125

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again?
PubMed
Journal
Int J Surg
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2.48
iCite
Revised in PubMed
2023-11-23
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chakraborty CChiranjib
2Bhattacharya MManojit
3Chopra HHiteshhttps://orcid.org/0000-0001-8867-7603
4Islam MAMd Aminulhttps://orcid.org/0000-0003-1091-9726
5Saikumar GGutullahttps://orcid.org/0000-0001-6492-4673
6Dhama KKuldeephttps://orcid.org/0000-0001-7469-4752

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
Mutation

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
41746044Dose-Dependent Efficacy of a Riboflavin and Ultraviolet Light-Inactivated Whole-Virion SARS-CoV-2 Vaccine in a Hamster Infection Challenge Model.Vaccines (Basel)2026https://conductscience.org/library/papers/41746044PubMed
41395483Evaluation of sampling methods for genomic surveillance of SARS-CoV-2 variants in aircraft wastewater: advancing global early-warning systems for future pandemics.Front Microbiol2025https://conductscience.org/library/papers/41395483PubMed
41295540Immune Responses to SARS-CoV-2 Variants WT and XBB.1.9: Assessing Vulnerabilities and Preparedness.Vaccines (Basel)2025https://conductscience.org/library/papers/41295540PubMed
41280906Impaired and restored CD8+ T cell responses to a sequentially mutated spike epitope in Omicron variants.Front Immunol2025https://conductscience.org/library/papers/41280906PubMed
41272150Programmable fluorescent aptamer-based RNA switches for rapid identification of point mutations.Nat Chem2025https://conductscience.org/library/papers/41272150PubMed
41234640SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation.Iran J Microbiol2025https://conductscience.org/library/papers/41234640PubMed
41120355An exploratory binding study of molnupiravir efficacy against emerging Omicron SARS-CoV-2 variants.Sci Rep2025https://conductscience.org/library/papers/41120355PubMed
40889205Monitoring SARS-CoV-2 Dissemination in Wastewater and Virus Isolation in Cell Cultures: An Integrated Approach for Pathogen Detection and Surveillance.J Cell Mol Med2025https://conductscience.org/library/papers/40889205PubMed
40733738Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus.Vaccines (Basel)2025https://conductscience.org/library/papers/40733738PubMed
40510757Comprehensive analysis of SARS-CoV-2 Spike evolution: epitope classification and immune escape prediction.Virus Evol2025https://conductscience.org/library/papers/40510757PubMed
40410660Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia.BMC Infect Dis2025https://conductscience.org/library/papers/40410660PubMed
40359081Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States.Emerg Infect Dis2025https://conductscience.org/library/papers/40359081PubMed
39816439Insights into Omicron: Genomic Characterization and Inpatient Risk Assessment at Single Tertiary Hospital in Indonesia.J Multidiscip Healthc2025https://conductscience.org/library/papers/39816439PubMed
39635731Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.Emerg Microbes Infect2025https://conductscience.org/library/papers/39635731PubMed
39536790Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea.J Korean Med Sci2024https://conductscience.org/library/papers/39536790PubMed
39452743A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon.Pathogens2024https://conductscience.org/library/papers/39452743PubMed
39449698Hospital-borne hazardous air pollutants and air cleaning strategies amid the surge of SARS-CoV-2 new variants.Heliyon2024https://conductscience.org/library/papers/39449698PubMed
39066238SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned.Viruses2024https://conductscience.org/library/papers/39066238PubMed
38824220CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis.Endocrine2024https://conductscience.org/library/papers/38824220PubMed
38793580SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.Viruses2024https://conductscience.org/library/papers/38793580PubMed

See all 28 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
VTN7448PubTator's text mininghttps://conductscience.org/library/genes/7448NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36917125

GET https://conductscience.org/api/papers/v1/36917125/cited_by?page=2